Product Code: ETC13221808 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Benign Prostatic Hyperplasia Treatment Devices Market was valued at USD 2.4 Billion in 2024 and is expected to reach USD 4 Billion by 2031, growing at a compound annual growth rate of 7.94% during the forecast period (2025-2031).
The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market is experiencing steady growth due to the increasing prevalence of BPH among aging male populations worldwide. BPH treatment devices such as prostate stents, catheters, and laser therapy systems are being increasingly adopted for managing BPH symptoms and improving patient outcomes. Technological advancements in minimally invasive procedures, coupled with a growing demand for effective and safe treatment options, are driving market expansion. North America and Europe currently dominate the market, but emerging economies in Asia-Pacific are expected to witness significant growth in the coming years. Key players in the market include Boston Scientific Corporation, Olympus Corporation, and Teleflex Incorporated, who are focusing on product innovation and strategic partnerships to gain a competitive edge in the global BPH treatment devices market.
The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market is witnessing a growing demand for minimally invasive procedures and technological advancements in treatment options. Key trends include the increasing adoption of laser therapy and water vapor therapy for BPH treatment, as they offer reduced side effects and quicker recovery times compared to traditional surgical methods. Additionally, there is a rising focus on developing personalized treatment approaches tailored to individual patient needs. Opportunities in the market lie in expanding product portfolios with innovative devices, strategic collaborations with healthcare providers for market penetration, and targeting emerging markets with high unmet medical needs. The market is expected to continue growing due to the increasing prevalence of BPH globally and the growing geriatric population driving the demand for effective treatment options.
The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market faces several challenges, including the high cost associated with these devices, limited awareness about BPH treatment options among patients, regulatory hurdles in different regions, and the presence of alternative treatment options such as medications and minimally invasive procedures. Additionally, the lack of skilled healthcare professionals proficient in using these devices, especially in emerging markets, poses a challenge for market growth. The competitive landscape with numerous companies offering similar products also adds to the challenges faced by players in this market. Overall, addressing these challenges will require innovative marketing strategies, increased educational efforts, cost-effective device development, and navigating complex regulatory environments to capitalize on the growing demand for BPH treatment devices.
The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market is primarily driven by the increasing prevalence of BPH among aging male populations, rising awareness about minimally invasive treatment options, technological advancements in BPH treatment devices, and the growing demand for effective and efficient treatment solutions. Additionally, the rising healthcare expenditure, favorable reimbursement policies for BPH treatment procedures, and the increasing adoption of advanced medical devices in emerging economies are also contributing to the market growth. The shift towards less invasive treatment procedures, such as laser therapy and prostatic artery embolization, is further propelling the demand for BPH treatment devices globally.Overall, the market is expected to continue expanding due to the aforementioned factors driving the adoption of BPH treatment devices worldwide.
Government policies related to the Global Benign Prostatic Hyperplasia Treatment Devices Market primarily focus on regulations surrounding the safety, efficacy, and quality of these medical devices. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require thorough testing and approval processes for BPH treatment devices to ensure patient safety and effectiveness. Additionally, reimbursement policies set by government healthcare programs play a significant role in market growth, as they influence healthcare providers and patients` access to these devices. Governments also encourage research and development in the field of BPH treatment devices through grants, tax incentives, and partnerships with industry stakeholders to drive innovation and improve patient outcomes.
The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market is expected to witness substantial growth in the coming years, fueled by an increasing aging population, rising prevalence of BPH, and advancements in minimally invasive treatment options. The market is likely to be driven by the demand for effective and less invasive treatment options that offer quicker recovery times and reduced side effects compared to traditional surgical methods. Technological innovations such as laser therapy, prostatic urethral lift procedures, and water vapor therapy are anticipated to gain traction, providing patients with more choices for managing BPH symptoms. Additionally, a growing awareness about the importance of early diagnosis and treatment of BPH among both patients and healthcare providers is expected to further propel market growth.
In the Global Benign Prostatic Hyperplasia Treatment Devices Market, Asia is anticipated to experience significant growth due to the increasing prevalence of BPH in countries like China and India. North America is expected to lead the market, driven by advanced healthcare infrastructure and high adoption rates of minimally invasive procedures. Europe is also a prominent market due to the presence of key players and rising awareness about BPH treatment options. The Middle East and Africa region is witnessing gradual growth, attributed to improving healthcare facilities and increasing focus on men`s health. Latin America is projected to show steady growth, supported by rising healthcare expenditure and improving access to BPH treatment devices in countries like Brazil and Mexico.
Global Benign Prostatic Hyperplasia Treatment Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Benign Prostatic Hyperplasia Treatment Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Benign Prostatic Hyperplasia Treatment Devices Market - Industry Life Cycle |
3.4 Global Benign Prostatic Hyperplasia Treatment Devices Market - Porter's Five Forces |
3.5 Global Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Global Benign Prostatic Hyperplasia Treatment Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Benign Prostatic Hyperplasia Treatment Devices Market Trends |
6 Global Benign Prostatic Hyperplasia Treatment Devices Market, 2021 - 2031 |
6.1 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Minimal Invasive Surgery, 2021 - 2031 |
6.1.3 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Invasive Surgery, 2021 - 2031 |
6.2 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Resectoscopes, 2021 - 2031 |
6.2.3 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Urology Laser, 2021 - 2031 |
6.2.4 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Radiofrequency Ablation, 2021 - 2031 |
6.2.5 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Electrodes, 2021 - 2031 |
6.2.6 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Catheters, 2021 - 2031 |
6.2.7 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Prostatic Stents, 2021 - 2031 |
6.2.8 Global Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
7.1 North America Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
8 Latin America (LATAM) Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
9 Asia Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
9.1 Asia Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
10 Africa Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
10.1 Africa Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
11 Europe Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
11.1 Europe Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
12 Middle East Benign Prostatic Hyperplasia Treatment Devices Market, Overview & Analysis |
12.1 Middle East Benign Prostatic Hyperplasia Treatment Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Benign Prostatic Hyperplasia Treatment Devices Market, Revenues & Volume, By Product, 2021 - 2031 |
13 Global Benign Prostatic Hyperplasia Treatment Devices Market Key Performance Indicators |
14 Global Benign Prostatic Hyperplasia Treatment Devices Market - Export/Import By Countries Assessment |
15 Global Benign Prostatic Hyperplasia Treatment Devices Market - Opportunity Assessment |
15.1 Global Benign Prostatic Hyperplasia Treatment Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Benign Prostatic Hyperplasia Treatment Devices Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Benign Prostatic Hyperplasia Treatment Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
16 Global Benign Prostatic Hyperplasia Treatment Devices Market - Competitive Landscape |
16.1 Global Benign Prostatic Hyperplasia Treatment Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Benign Prostatic Hyperplasia Treatment Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |